videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    isPremium
    summary
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

isPremium

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

first

order

upcoming

edges

Pharma Equity Group

Meet and ask questions to CEO Thomas K. Selsø from Pharma Equity Group on Monday, December 11th, 2023 at 2 PM. CEO Thomas K. Selsø will provide an update on what has happened in 2023 and outline focus areas for 2024 which will be followed by a Q&A session. No question is too big or too small, everyone should have the opportunity to ask questions.


Meet and ask questions to CEO Thomas K. Sels&oslash; from Pharma Equity Group on Monday, December 11th, 2023 at 2 PM. CEO Thomas K. Sels&oslash; will provide an update on what has happened in 2023 and outline focus areas for 2024 which will be followed by a Q&amp;A session. No question is too big or too small, everyone should have the opportunity to ask questions. Pharma Equity Group focuses on repositioning existing APIs (Active Pharmaceutical Ingredients) for other indications. Pharma Equity Group acquired a larger portfolio of phase 2 projects through the purchase of Reponex, within major disease areas. These include bacterial peritonitis, chronic skin wounds, inflammatory bowel diseases, as well as colon and rectal cancer. The company operates with a partnership structure for all its phase 3 projects. Disclaimer: HC Andersen Capital receives payment from Pharma Equity Group for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 20.11.2023, 2.45 PM.

HC Andersen Capital

Pharma Equity Group - Market Update & Q&A

Raute

Tämä osake on halpa syklin kääntyessä

Dustin Group

Dustin Group, Audiocast, Q2'26

Titanium

Mitä huomioida, kun sijoitussalkkua rakennetaan? ft. Mikko Ervasti | Salkunhoitajat

Siili Solutions

Siili Solutionsin yhtiökokous | Toimitusjohtajan katsaus 8.4.2026

Revenio Group

Revenio tuplaa kokonsa jättikaupassa

Viimeisimmät videot